BCLI
BRAINSTORM CELL THERAPUTC
BCLI
BCLI
Delisted
BCLI was delisted on the 17th of July, 2025.
43 hedge funds and large institutions have $6.16M invested in BRAINSTORM CELL THERAPUTC in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 11 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
36% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 11
64% less capital invested
Capital invested by funds: $17.1M → $6.16M (-$11M)
Holders
43
Holding in Top 10
–
Calls
$847K
Puts
$130K
Top Buyers
| 1 | +$174K | |
| 2 | +$40.3K | |
| 3 | +$27.8K | |
| 4 |
Jane Street
New York
|
+$23K |
| 5 |
SCFS
S.C. Financial Services
Scottsdale,
Arizona
|
+$20.8K |
Top Sellers
| 1 | -$166K | |
| 2 | -$71K | |
| 3 | -$70.6K | |
| 4 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$52.6K |
| 5 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
-$51K |